Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001par value per share, of Achieve Life Sciences, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: January 20, 2023
| Dialectic Capital Management, LP | |||
| By: | Dialectic Partners, LLC | ||
| General Partner | |||
|
/s/ John Fichthorn | |||
| Name: | John Fichthorn | ||
| Title: | Managing Member | ||
| Dialectic Partners, LLC | |||
| By: |
/s/ John Fichthorn | ||
| Name: | John Fichthorn | ||
| Title: | Managing Member | ||
| Dialectic Life Sciences SPV LLC | |||
| By: | Dialectic LS Manager LLC | ||
Managing Member | |||
| By: |
/s/ John Fichthorn | ||
| Name: | John Fichthorn | ||
| Title: | Managing Member | ||
| Dialectic LS Manager LLC | |||
| By: |
/s/ John Fichthorn | ||
| Name: | John Fichthorn | ||
| Title: | Managing Member | ||
|
/s/ John Fichthorn | |
| John Fichthorn |